Comparing placental diffusion in diabetic and healthy pregnant women
Official title: Characterization of Placental Diffusion in Women With Diabetes Using DW-MRI
Run by Hillel Yaffe Medical Center · NCT06992245 · Data updated 2026-11-12
This study is testing if using special MRI scans can help understand how the placenta works in pregnant women with uncontrolled diabetes compared to healthy pregnant women, to see if it affects the baby’s oxygen levels.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | Women only |
| Enrollment | 40 (estimated) |
| Sponsor | Hillel Yaffe Medical Center Government |
| Locations | 1 site (Hadera) |
| Status | Recruiting |
| Started | July 6, 2023 |
| Main results expected | December 2027 |
| Study ends | December 2027 |
| Registry record updated | December 24, 2025 |
| Trial ID | NCT06992245 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include pregnant women diagnosed with pre-gestational or gestational diabetes.
✕Probably not a fit
Patients with a history of placental hypoxia disease or those in active labor may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study uses diffusion-weighted MRI (DW-MRI) to assess and compare placental diffusion in pregnant women with uncontrolled diabetes against healthy pregnant women. The goal is to investigate the relationship between placental diffusion and potential fetal hypoxia, which may contribute to fetal death. By identifying changes in placental diffusion, the researchers hope to uncover mechanisms behind fetal damage and develop predictive protocols for at-risk pregnancies.
Why it matters
Potential benefit: If successful, this study could lead to better understanding and prediction of fetal risks in pregnancies complicated by diabetes.
How similar studies have gone: While the approach of using DW-MRI for placental assessment is promising, it is relatively novel and has not been extensively tested in similar studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women with PGAM (Pre-gestational diabetes) diagnosed before 20 weeks of pregnancy * Women with GDMA (Gestational diabetes) diagnosed by OGTT after 20 weeks of pregnancy Exclusion Criteria: * pregnant women with placental hypoxia disease related in the past * pregnant women with placental hypoxia disease related in the present * non-singleton pregnancy * women in active labor or rupture of membrane * smoking women * suspicion of placenta accreta
Where it's running
-
Hille Yaffe Medical Center
Hadera, Israel Recruiting
Study contacts
- Principal investigator: Rinat Gabbay-Benziv, Prof — Hillel Yaffe Medical Center
- Study coordinator: Rinat Gabbay-Benziv, Prof
- Email: rinatg@hymc.gov.il
- Phone: +972-4-7744514
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding how tuberculosis affects the placenta during pregnancy
This study is trying to see how tuberculosis affects the placenta and pregnancy outcomes in women giving birth in Ethiopia.
-
Evaluating fetal hyperinsulinemia using ultrasound radiomics
This study is testing if special ultrasound images can help tell if babies are at risk for high insulin levels when their mothers have type 1 diabetes, compared to healthy pregnancies.
-
Comparing glucose monitoring methods in pregnant women with gestational diabetes after gastric bypass surgery
This study is testing whether continuous glucose monitoring works better than traditional blood sugar checks for pregnant women with gestational diabetes who have had gastric bypass surgery.
-
Examining how pregnancy factors affect the risk of type 1 diabetes in children
This study is trying to see how different factors during pregnancy might affect the chances of children developing type 1 diabetes.
-
Randomized comparison of immediate in-hospital 2-hour OGTT versus standard 4–12 week postpartum 2-hour OGTT for people with gestational diabetes
This will test whether doing a 2-hour OGTT before hospital discharge gets more people who had gestational diabetes screened for diabetes than the usual 4–12 week outpatient test.
-
Impact of obesity, diabetes, and bariatric surgery on pregnancy outcomes
This study looks at how being overweight, having diabetes, or having had weight-loss surgery affects pregnancy outcomes for women compared to those with a normal weight.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.